BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fahmy UA, Ahmed OAA, Badr-Eldin SM, Aldawsari HM, Okbazghi SZ, Awan ZA, Bakhrebah MA, Alomary MN, Abdulaal WH, Medina C, Alhakamy NA. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin. Int J Nanomedicine 2020;15:5253-64. [PMID: 32801690 DOI: 10.2147/IJN.S258791] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Formica ML, Real DA, Picchio ML, Catlin E, Donnelly RF, Paredes AJ. On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Applied Materials Today 2022;29:101631. [DOI: 10.1016/j.apmt.2022.101631] [Reference Citation Analysis]
2 Alrashedi MG, Ali AS, Ahmed OA, Ibrahim IM. Local Delivery of Azithromycin Nanoformulation Attenuated Acute Lung Injury in Mice. Molecules 2022;27:8293. [DOI: 10.3390/molecules27238293] [Reference Citation Analysis]
3 Alghaith AF, Mahrous GM, Shazly GA, Zidan DEZ, Alhamed AS, Alqinyah M, Almutairi MM, Syed SA. The Optimization and Evaluation of Flibanserin Fast-Dissolving Oral Films. Polymers 2022;14:4298. [DOI: 10.3390/polym14204298] [Reference Citation Analysis]
4 de Barros C, Portugal I, Batain F, Portella D, Severino P, Cardoso J, Arcuri P, Chaud M, Alves T. Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems. RPS Pharmacy and Pharmacology Reports 2022;1. [DOI: 10.1093/rpsppr/rqac003] [Reference Citation Analysis]
5 Ahmed OAA, Badr-Eldin SM, Caruso G, Fahmy UA, Alharbi WS, Almehmady AM, Alghamdi SA, Alhakamy NA, Mohamed AI, Aldawsari HM, Mady FM. Colon targeted Eudragit coated beads loaded with optimized fluvastatin-scorpion venom conjugate as a potential approach for colon cancer therapy: in vitro anticancer activity and in vivo colon imaging. J Pharm Sci 2022:S0022-3549(22)00354-9. [PMID: 36007556 DOI: 10.1016/j.xphs.2022.08.020] [Reference Citation Analysis]
6 Ali AS, Alrashedi MG, Ahmed OAA, Ibrahim IM. Pulmonary Delivery of Hydroxychloroquine Nanostructured Lipid Carrier as a Potential Treatment of COVID-19. Polymers 2022;14:2616. [DOI: 10.3390/polym14132616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Badr-eldin SM, Aldawsari HM, Alhakamy NA, Fahmy UA, Ahmed OAA, Neamatallah T, Tima S, Almaghrabi RH, Alkudsi FM, Alamoudi AA, Alzahrani AA, Kotta S, Al-hejaili OD. Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells. Pharmaceutics 2022;14:1024. [DOI: 10.3390/pharmaceutics14051024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Cunha S, Swedrowska M, Bellahnid Y, Xu Z, Sousa Lobo J, Forbes B, Silva A. Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121720] [Reference Citation Analysis]
9 Alhakamy NA, Okbazghi SZ, A. Alfaleh M, H. Abdulaal W, Bakhaidar RB, Alselami MO, Zahrani MA, Alqarni HM, F. Alghaith A, Alshehri S, Badr-eldin SM, Aldawsari HM, Al-hejaili OD, Aldhabi BM, Mahdi WA. Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells. PLoS ONE 2022;17:e0264093. [DOI: 10.1371/journal.pone.0264093] [Reference Citation Analysis]
10 Nayak AK, Hasnain MS, Behera A, Dhara AK, Pal D. Biological macromolecules in drug delivery. Biological Macromolecules 2022. [DOI: 10.1016/b978-0-323-85759-8.00015-4] [Reference Citation Analysis]
11 Abdelkader H, Fathalla Z, Seyfoddin A, Farahani M, Thrimawithana T, Allahham A, Alani AWG, Al-Kinani AA, Alany RG. Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants. Adv Drug Deliv Rev 2021;177:113957. [PMID: 34481032 DOI: 10.1016/j.addr.2021.113957] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
12 Alghaith AF, Mahrous GM, Zidan DE, Alhakamy NA, Alamoudi AJ, Radwan AA. Preparation, characterization, dissolution, and permeation of flibanserin - 2-HP-β-cyclodextrin inclusion complexes. Saudi Pharm J 2021;29:963-75. [PMID: 34588842 DOI: 10.1016/j.jsps.2021.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Alhakamy NA, Al-Rabia MW, Md S, Sirwi A, Khayat SS, AlOtaibi SS, Hakami RA, Al Sadoun H, Eldakhakhny BM, Abdulaal WH, Aldawsari HM, Badr-Eldin SM, Elfaky MA. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021;13:977. [PMID: 34203359 DOI: 10.3390/pharmaceutics13070977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]